跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sandine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sandine
Approved
STANDARD
Sandine
SRS Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
84a8f32adf1e3b16
Company
SRS Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
84a8f32adf1e3b16
Drug Approval Philippines Name
Sandine
Product Name
Sandine
Registration Number
DRP-2297
Brand Name
Sandine
Generic Name
Norepinephrine (as bitartrate)
Dosage Form
Solution For Injection (Iv)
Dosage Strength
1mg/mL (2mg/2mL) and (4mg/4mL)
Manufacturer
SRS Pharmaceuticals Pvt. Ltd.
Importer
SRS Life Sciences Inc.
Distributor
Philcare Pharma, Inc.
Issuance Date
25 July 2024
Expiry Date
09 October 2029
Pharmacologic Category
Adrenergic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
84a8f32adf1e3b16
Type
Standard
Back to Philippines FDA Approvals